We are live on ! Find out more
WCA

Westover Capital Advisors Portfolio holdings

AUM $602M
1-Year Est. Return 37.09%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+37.09%
3 Year Est. Return
+133.23%
5 Year Est. Return
+171.88%
10 Year Est. Return
+595.98%
AUM
$454M
AUM Growth
-$65.9M
Cap. Flow
-$80.4M
Cap. Flow %
-17.7%
Top 10 Hldgs %
35.01%
Holding
255
New
12
Increased
32
Reduced
120
Closed
18

Top Buys

Rank Stock Value
1
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$1.79M
2
USFD icon
US Foods
USFD
+$1.12M
3
PR
Permian Resources
PR
+$983K
4
CTVA icon
Corteva
CTVA
+$966K
5
NVDA icon
NVIDIA
NVDA
+$892K

Sector Composition

Rank Sector Weight
1 Technology 26.98%
2 Miscellaneous 20.46%
3 Financials 9.99%
4 Communication Services 8.06%
5 Healthcare 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
176
Freeport-McMoran
FCX
$99.6B
$343K 0.08%
9,000
JMOM icon
177
JPMorgan US Momentum Factor ETF
JMOM
$2.68B
$342K 0.08%
5,869
-5,485
-48% -$325K
ALSN icon
178
Allison Transmission
ALSN
$10.1B
$342K 0.08%
3,161
WSFS icon
179
WSFS Financial
WSFS
$4.12B
$329K 0.07%
6,185
ETN icon
180
Eaton
ETN
$152B
$327K 0.07%
984
PG icon
181
Procter & Gamble
PG
$341B
$326K 0.07%
1,944
BHP icon
182
BHP
BHP
$215B
$326K 0.07%
6,669
ARCB icon
183
ArcBest
ARCB
$3.01B
$325K 0.07%
3,481
-294
-8% -$31.1K
QCOM icon
184
Qualcomm
QCOM
$201B
$323K 0.07%
2,105
+120
+6% +$19.6K
CDW icon
185
CDW
CDW
$19.2B
$321K 0.07%
1,843
-30
-2% -$5.83K
SRPT icon
186
Sarepta Therapeutics
SRPT
$2.19B
$319K 0.07%
2,625
PLD icon
187
Prologis
PLD
$129B
$311K 0.07%
2,945
-33
-1% -$3.79K
JQUA icon
188
JPMorgan US Quality Factor ETF
JQUA
$8.75B
$308K 0.07%
5,377
-5,043
-48% -$292K
PH icon
189
Parker-Hannifin
PH
$117B
$304K 0.07%
478
-13
-3% -$8.61K
TDG icon
190
TransDigm Group
TDG
$60B
$303K 0.07%
+239
New +$315K
WES icon
191
Western Midstream Partners
WES
$19.5B
$296K 0.07%
7,700
WLK icon
192
Westlake Corp
WLK
$8.95B
$293K 0.06%
2,555
-262
-9% -$34.1K
VEA icon
193
Vanguard FTSE Developed Markets ETF
VEA
$234B
$292K 0.06%
6,103
IWO icon
194
iShares Russell 2000 Growth ETF
IWO
$14.1B
$288K 0.06%
1,000
C icon
195
Citigroup
C
$228B
$279K 0.06%
3,962
PJT icon
196
PJT Partners
PJT
$3.97B
$274K 0.06%
1,736
MCHP icon
197
Microchip Technology
MCHP
$38.8B
$273K 0.06%
4,766
ETR icon
198
Entergy
ETR
$49.2B
$273K 0.06%
3,600
FNDX icon
199
Schwab Fundamental US Large Company Index ETF
FNDX
$27.7B
$272K 0.06%
11,474
-11,110
-49% -$269K
CM icon
200
Canadian Imperial Bank of Commerce
CM
$103B
$266K 0.06%
4,200

Similar funds

Westover Capital Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Westover Capital Advisors held 255 positions worth $454M, down 13% from $520M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Westover Capital Advisors withdrew a net $80.4M in Q4 2024, closing 18 positions and reducing 120 holdings. Its most notable exit was AstraZeneca, an estimated $844K position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, Westover Capital Advisors opened a new position in Janus Henderson AAA CLO ETF worth $1.79M.

  • Westover Capital Advisors's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 35,269 shares worth $1.79M.
  • Westover Capital Advisors added most to US Foods in Q4 2024, an estimated $1.12M increase.
  • Westover Capital Advisors's biggest Q4 2024 reduction was State Street SPDR Portfolio Long Term Treasury ETF, cutting an estimated $11M.
  • Westover Capital Advisors fully exited AstraZeneca in Q4 2024, selling an estimated $844K.
  • Westover Capital Advisors's ten largest holdings make up 35% of its $454M portfolio in Q4 2024.
  • Westover Capital Advisors opened 12 new positions and closed 18 in Q4 2024.
  • Westover Capital Advisors's portfolio value fell 13% quarter-over-quarter to $454M.

Based on Westover Capital Advisors's 13F filing for Q4 2024, filed 6 Feb 2025.